<mods:mods version="3.3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mods="http://www.loc.gov/mods/v3"><mods:titleInfo><mods:title>ADRENORETSEPTORLARNI QO‘ZG‘ATUVCHI VOSITALAR</mods:title></mods:titleInfo><mods:name type="personal"><mods:namePart type="given">Kibriyeva Maxfirat</mods:namePart><mods:namePart type="family">Abdurakhmonova</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:name type="personal"><mods:namePart type="given">Boysariyeva Jasmina Murod</mods:namePart><mods:namePart type="family">qizi</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:abstract>Ushbu maqolada adrenoretseptorlarni qo‘zg‘atuvchi vositalarning (adrenomimetiklarning) farmakologik xususiyatlari, ta’sir mexanizmlari, tasnifi va klinik amaliyotdagi ahamiyati tahlil qilindi. Adrenomimetik preparatlar α- va β-adrenoretseptorlarga ta’sir etib, yurak-qon tomir, nafas olish va boshqa tizimlar faoliyatini boshqarishda muhim o‘rin tutadi. Tadqiqot davomida farmakologiya bo‘yicha yetakchi darsliklar va ilmiy adabiyotlar ma’lumotlari tahlil qilindi. Natijalar adrenomimetik vositalarning arterial gipotenziya, anafilaktik shok, bronxial astma, yurak yetishmovchiligi va boshqa patologik holatlarni davolashda yuqori samaradorlikka ega ekanligini ko‘rsatdi. Shu bilan birga, ushbu preparatlarni qo‘llashda nojo‘ya ta’sirlar va xavfsizlik masalalariga alohida e’tibor qaratilishi zarurligi aniqlandi.</mods:abstract><mods:originInfo><mods:dateIssued encoding="iso8601">2026-06-04</mods:dateIssued></mods:originInfo><mods:originInfo><mods:publisher>Research Science and Innovation House</mods:publisher></mods:originInfo><mods:genre>Maqola</mods:genre></mods:mods>